Agile's product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method.
Agile Therapeutics reveals data from comparative wear study on its contraceptive patch Twirla
Quick facts: Agile Therapeutics
Price: 2.18 USD
Market Cap: $189.79 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Agile Therapeutics named herein, including the promotion by the Company of Agile Therapeutics in any Content on the Site, the Company receives...FOR OUR FULL DISCLAIMER CLICK HERE